Company
Genzyme
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
0
510(k), De Novo and PMA
Device trials
17
As lead sponsor, any status
Adverse event reports
29
Received Nov 1, 2025 to Nov 19, 2026
Recall records
29
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Genzyme, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Genzyme.
Latest FDA decisions
No 510(k), De Novo or PMA decisions under this name since 2015.
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the KneePivotal-lookingCompleted
NCT03190369 · 440 participants · Start Aug 21, 2017 · Primary completion Jan 28, 2019
Device: Hylan G-F 20 (GZ402662/SAR402662) · For: Osteoarthritis
Sites: Beijing, China; Changchun, China; Changsha, China · 21 sites in all
NCT00131326 · Start Nov 2003
Device: Synvisc (hylan G-F 20) · For: Osteoarthritis, Hip; Musculoskeletal Diseases
Sites: Birmingham, Alabama; Huntsville, Alabama; Scottsdale, Arizona · 32 sites in all
NCT00624390 · 41 participants · Start Nov 2007 · Primary completion Dec 2008
Device: Sepraspray · For: Laparoscopic Myomectomy
Sites: Naperville, Illinois; Philadelphia, Pennsylvania; Austin, Texas
14 more trials with a free account
Reports received
29
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
4
14% of reports
Injury reports
21
72% of reports
Death reports
3
10% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 4 | 1 | 0 |
| Jan 24 | 1 | 3 | 0 | 0 |
| Feb 24 | 0 | 6 | 1 | 0 |
| Mar 24 | 0 | 5 | 2 | 0 |
| Apr 24 | 0 | 5 | 0 | 0 |
| May 24 | 0 | 5 | 0 | 0 |
| Jun 24 | 0 | 3 | 0 | 0 |
| Jul 24 | 0 | 3 | 3 | 0 |
| Aug 24 | 0 | 3 | 0 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 0 | 6 | 0 | 0 |
| Nov 24 | 1 | 9 | 1 | 1 |
| Dec 24 | 2 | 10 | 0 | 0 |
| Jan 25 | 0 | 8 | 1 | 0 |
| Feb 25 | 0 | 4 | 0 | 0 |
| Mar 25 | 0 | 5 | 0 | 0 |
| Apr 25 | 0 | 1 | 0 | 0 |
| May 25 | 0 | 4 | 1 | 0 |
| Jun 25 | 0 | 12 | 1 | 0 |
| Jul 25 | 2 | 1 | 0 | 0 |
| Aug 25 | 0 | 1 | 0 | 0 |
| Sep 25 | 1 | 5 | 0 | 0 |
| Oct 25 | 1 | 1 | 0 | 1 |
| Nov 25 | 0 | 1 | 0 | 0 |
| Dec 25 | 0 | 5 | 2 | 0 |
| Jan 26 | 1 | 2 | 0 | 0 |
| Feb 26 | 0 | 4 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 0 | 2 | 0 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 1 | 2 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 4 | 1 | 1 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
6 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0607-2018 · Started Dec 11, 2017
Reason given: Contamination with Methylbacterium thiocyanatum
Cause as FDA categorized it: Environmental control · Device type: Acid, Hyaluronic, Intraarticular (MOZ)
Z-2139-2013 · Started Jun 21, 2013 · Posted by FDA Sep 3, 2013
Reason given: Product contains particulates (fibers)
Cause as FDA categorized it: Material/Component Contamination · Device type: Occluder, Internal Vessel, Temporary (OBC)
Z-2140-2013 · Started Jun 21, 2013 · Posted by FDA Sep 3, 2013
Reason given: Product contains particulates (fibers)
Cause as FDA categorized it: Material/Component Contamination · Device type: Occluder, Internal Vessel, Temporary (OBC)
26 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.